The other thing the committee is looking at right now, in the context of both PMPRB reform and access to vaccines, is the concept of the government's role and what the government has done in terms of supporting research and pharmaceutical research, particularly in the private sector in Canada, and then what the trade-off should be.
In bullet-point format, in 30 seconds or less, what are the types of subsidies that government would give to pharma right now, including intellectual property protection frameworks?